Related Experiment Video
Updated: Aug 8, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases
I Takenaka1, F Morin, B R Seizinger
1Department of Molecular Genetics and Cell Biology, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
Abstract:
The p53 tumor suppressor protein is a transcription factor with sequence-specific DNA binding activity that is thought to be important for the growth-inhibitory function of p53. DNA binding appears to require activation of a cryptic form of p53 by allosteric mechanisms involving a negative regulatory domain at the carboxyl terminus of p53. The latent form of p53, reactive to the carboxyl-terminal antibody PAb421, is produced in a variety of eukaryotic cells, suggesting that activation of p53 is an important rate-limiting step in vivo. In this report we provide evidence that phosphorylation of serine 378 within the carboxyl-terminal negative regulatory domain of the human p53 protein by protein kinase C correlates with loss of PAb421 reactivity and a concomitant activation of sequence-specific DNA binding. These effects are reversed by subsequent dephosphorylation of the protein kinase C-reactive site by protein phosphatases 1 (PP1) and 2A (PP2A), which restore the reactivity of p53 to PAb421 and regenerate the latent form of p53 lacking significant DNA binding activity. Thus, p53 is subject to both positive and negative regulation by reversible enzymatic modifications affecting the latent or active state of the protein, suggesting a possible mechanism for the regulation of its tumor suppressor function.
Insights
The p53 tumor suppressor protein
Area of Science:
- Molecular Biology
- Cellular Biology
- Biochemistry
Background:
- The p53 protein acts as a tumor suppressor by regulating cell growth.
- Its DNA binding activity is crucial for its growth-inhibitory function.
- p53 activation involves allosteric mechanisms and a negative regulatory domain.
Purpose of the Study:
- To investigate the role of phosphorylation in regulating p53 DNA binding activity.
- To identify the specific site and enzymes involved in p53 regulation.
- To elucidate the reversible nature of p53 activation and its implications for tumor suppression.
Main Methods:
- Utilized antibody PAb421 to detect the latent form of p53.
- Investigated the effect of protein kinase C (PKC) phosphorylation on p53.
- Examined the role of protein phosphatases 1 (PP1) and 2A (PP2A) in dephosphorylation.
- Assessed changes in DNA binding activity and PAb421 reactivity.
Main Results:
- Phosphorylation of serine 378 by PKC inactivates the latent p53 form, reducing PAb421 reactivity.
- This phosphorylation event activates p53's sequence-specific DNA binding.
- Dephosphorylation by PP1 and PP2A reverses these effects, restoring latent p53 and inhibiting DNA binding.
Conclusions:
- p53 activity is regulated by reversible phosphorylation at serine 378.
- Protein kinase C and phosphatases PP1/PP2A act as key regulators of p53's latent and active states.
- This reversible enzymatic modification provides a mechanism for controlling p53's tumor suppressor function.
Related Concept Videos
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle

